Current landscape and trends in transdermal drug delivery systems

Therapeutic Delivery

Volumn 3, Issue 3, 2012, Pages 295-297

  Yeoh, Thean ^a  

^a PFIZER INC   (United States)

Author keywords

drug delivery; generic patch; life cycle management; microneedles; pain; transdermal patch

Indexed keywords

ADRENALIN; CLONIDINE; EMLA; FENTANYL; GENERIC DRUG; LIDOCAINE; LIDOCAINE PLUS TETRACAINE; RIVASTIGMINE; SCOPOLAMINE;

ANALGESIA; CHRONIC DRUG ADMINISTRATION; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; CREAM; DEMENTIA; DISEASE CONTROL; DRUG APPROVAL; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; HERPES ZOSTER OTICUS; HUMAN; HYPERTENSION; NAUSEA; PAIN; PATIENT COMPLIANCE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; SUSTAINED DRUG RELEASE; TABLET; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT PLANNING; TREND STUDY; VOMITING;

EID: 84858119424     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.11     Document Type: Review

References (8)

1. Yeoh T. Profiles of recently approved transdermal drug delivery systems (TDDS). Part 1: Exelon patch-example of life cycle strategy for successful products; generic clonidine transdermal systems-design and delivery attributes. TransDermal Mag. 3(4), 10-17 (2011).
2. Yeoh T. Profiles of recently approved transdermal drug delivery systems (TDDS). Part II: Matrix-type fentanyl transdermal systems-design variation and delivery attributes. TransDermal Mag. 3(5), 9-15 (2011).
3. Zempsky WT. Reduction of pain associated with minor procedures in children-new topical anesthetics on the horizon. Touch Briefings. Business Briefing: US pediatric Care. 19-22 (2005).
4. Hill L. Joining the transdermal pipeline. TransDermal Mag. 3(4), 5-8 (2011).
5. Schmid EF, Smith DA. Is declining innovation in the pharmaceutical industry a myth? Drug Discov. Today 10(15), 1031-1039 (2005). (Pubitemid 41074141)
6. Guidance for industry. Residual Drug in Transdermal and Related Drug Delivery Systems. US, Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), August 2011.
7. Lamberta PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine, 26, 26, 3197-3208 (2008).
8. Lehman PA. Analysis of new FDA draft guidances: insights on study designs for bioequivalence assessment of transdermal systems. Drug Develop. Deliv. 11(3), 36-41 (2011).